YIFAN PHARMACEUTICAL CO (SZSE:002019) Accounts Payable & Accrued Expense : ¥1,107 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Accounts Payable & Accrued Expense?

YIFAN PHARMACEUTICAL CO's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥738 Mil) to Dec. 2023 (¥946 Mil) and increased from Dec. 2023 (¥946 Mil) to Mar. 2024 (¥1,107 Mil).

YIFAN PHARMACEUTICAL CO's annual accounts payable & accrued expense declined from Dec. 2021 (¥761 Mil) to Dec. 2022 (¥745 Mil) but then increased from Dec. 2022 (¥745 Mil) to Dec. 2023 (¥946 Mil).

YIFAN PHARMACEUTICAL CO Accounts Payable & Accrued Expense Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Accounts Payable & Accrued Expense Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

987.42

841.71

761.14

745.40

945.54

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															717.96	753.93	737.57	945.54	1,106.72

YIFAN PHARMACEUTICAL CO Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

Executives

Ye Yi Qun	Director
Zhang Da Wei	Executives
Geng Yu Hong	Executives
Feng De Qi	Directors, Directors, and Executives
Zhou Ben Yu	Director
Lin Xing	Directors, executives
Yu Hai Xia	Executives
Cheng Xian Feng	Directors, executives
Xu Guo Han	Supervisors
Cao Shi Mei	Director
Lin Guan Yu	Director
Zhang Lian Chun	Executives
Guo Xin Fu	Director
Zheng Shi Ming	Supervisors
Yin Hang Hua	Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines